FinTrust Capital Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

FinTrust Capital Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36	Closed	-$2.25K	–	1365
2023 Q2	$2.25K	Hold	36	–	–	﹤0.01%	987
2023 Q1	$2.25K	Hold	36	–	–	﹤0.01%	979
2022 Q4	$2.25K	Sell	36 -111	-76%	-$7.37K	﹤0.01%	976
2022 Q3	$10K	Buy	+147	New	+$10.1K	﹤0.01%	886

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FinTrust Capital Advisors's AXNX Position: Q3 2023 in Review

FinTrust Capital Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 36 shares — an estimated $2.25K sold.

FinTrust Capital Advisors first reported a position in AXNX in Q3 2022 and held it in 4 quarters. The position peaked at $10K in Q3 2022. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

FinTrust Capital Advisors reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
FinTrust Capital Advisors sold 36 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $2.25K.
FinTrust Capital Advisors first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
FinTrust Capital Advisors's Axonics, Inc. Common Stock position peaked at $10K in Q3 2022.
221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on FinTrust Capital Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.